Artificial Intelligence (AI) and Pathology
Podcast | English | 40 Min
Image For Activity Cover
No Credit Offered

Artificial intelligence is one of the most significant trends in most parts of society. Increasingly, oncologists and lung cancer researchers are including AI as part of their research and patient care. In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion of this compelling technology, focusing on its promise and limitations.

Podcast Host:
  • Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and Thoracic Medical Oncologist, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School, USA  

Podcast Guests: 

  • Sanja Dacic, MD, PhD, MSc, Vice Chair and Director of Anatomic Pathology, Yale University Medical School, USA
  • Fabio Ynoe de Moraes, MD, PhD, MBA, Assistant Professor & Radiation Oncologist, Queen's University, Kingston Health Sciences Centre, Canada 
Powered By